These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


86 related items for PubMed ID: 6160823

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Central neurotropic activity of homovanillic acid.
    Kleinrok Z, Zarkowski AM.
    Acta Physiol Pol; 1981; 32(5):477-85. PubMed ID: 7336983
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
    Zebrowska-Lupina I, Malec D, Kleinrok Z.
    Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
    Kleinrok Z, Szponar J, Matuszek B, Jagiełło-Wójtowicz E.
    Pol J Pharmacol Pharm; 1990; 42(5):417-24. PubMed ID: 2098751
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of central action of octopamine.
    Jagiełło-Wójtowicz E.
    Pol J Pharmacol Pharm; 1979; 31(5):509-16. PubMed ID: 121158
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Central action of drugs acting on the cholinergic muscarinic receptor. II. Influence of ecothiopate administered into the lateral cerebral ventricle on behavior in rats.
    Kleinrok Z, Wielosz M, Przegaliński E.
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):477-84. PubMed ID: 1172420
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB, Luttinger D, Hernandez DE, Mailman RB, Mason GA, Davis SD, Widerlöv E, Frye GD, Kilts CA, Beaumont K, Breese GR, Prange AJ.
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [Abstract] [Full Text] [Related]

  • 19. Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L.
    Kleinrok Z, Jagiełło-Wójtowicz E, Matuszek B, Chodkowska A.
    Pol J Pharmacol Pharm; 1992 May; 44(3):227-39. PubMed ID: 1470561
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.